Sumitomo Dainippon Pharma completes acquisition of Canada's Cynapsus Therapeutics
MLex Summary: Sumitomo Dainippon Pharma has completed the acquisition of Canada’s Cynapsus Therapeutics, the Japanese company said in a statement today. The purchase was made through Sunovion Pharmaceuticals, a wholly owned...To view the full article, register now.
Already a subscriber? Click here to view full article